MiR-574-3p and miR-125a-5p in adipose derived mesenchymal stem cell exosomes synergistically target TGF-β1SMAD2 signaling pathway for the treatment of androgenic alopecia
Ontology highlight
ABSTRACT: Androgenetic alopecia (AGA) is the most common hair loss disorder, influenced by distinct genetic factors and intricate environmental factors. The exosomes (Exo) from adipose-derived mesenchymal stem cells (ADMSCs) have diverse effects, including the promotion of cell proliferation, inhibition of apoptosis, analgesia, and enhancement of wound healing. The miRNAs are essential components of the paracrine secretion of ADMSCs-Exo. This study revealed that ADMSCs-Exo could counteract the impairment of dermal papilla cells (DPCs) induced by dihydrotestosterone (DHT) by inhibiting the TGF-β1 signaling pathway`s activation.However, the exosomes derived from ADMSCs adipogenic differentiation (ADMSCsAd-Exo) lacked this therapeutic potential. Expression profiling of miRNAs in ADMSCs-Exo and ADMSCsAd-Exo by genomic microarray analysis. MiR-574-3p and miR-125a-5p, were identified as being predominantly expressed and specifically targeting TGF-β1 and SMAD2, respectively. Ultimately, our findings indicate that ADMSCs-Exo target the TGF-β1/SMAD2 signaling pathway via miR-574-3p and miR-125a-5p, are integral to their therapeutic action on DHT-induced DPCs and AGA murine models. This discovery offers significant insights into the pathogenesis of AGA and suggests potential therapeutic approaches. Further investigation into the role and interaction of these miRNAs in ADMSCs-Exo may lead to the development of more precise and efficacious treatments for AGA.
ORGANISM(S): Homo sapiens
PROVIDER: GSE281527 | GEO | 2025/04/17
REPOSITORIES: GEO
ACCESS DATA